In addition, we have found that the IL-17 pathway in the toxicity target enrichment pathway plays a key role in the pathological process of a variety of inflammatory reactions and autoimmune diseases, including the toxic and side effects of a variety of LGT such as acute renal failure and liver dysfunction. Here, IL17A is linked to autoimmune disease.